Lecture 23- Reproductive tract tumours Flashcards
Tumour-
any clinically detectable lump or swellingTumour- any clinically detectable lump or swelling
Neoplasm –
an abnormal growth of cells that persists after the initial stimulus is removed
Malignant neoplasm-
an abnormal growth of cells that persists after the initial stimulus is removed and invades surround tissue with potential to spread to distant sites
Metastasis-
malignant neoplasm that has spread to a distant site
Dysplasia-
a potentially pre- neoplastic alteration which cells show disordered organisation and abnormal appearances. May be reversible
Metaplasia-
conversion in cell type
features of vulval tumours
- External vagina
- Rare – 3% of female cancers
- Older people (peak onset 80-84)
- Skin cancer
vulval cancer is most commonly
squamous cell carcinoma (skin cancer)
- Can also see basal cell carcinoma or malignant melanoma less commonly
- Rarely see soft tissue tumours
- From fat cells, blood vessels and nerves
Precursor to vulval squamous cell carcinoma =
Vulval intraepithelial neoplasia (VIN)
Vulval intraepithelial neoplasia (VIN)
- In Situ precursor of vulval squamous cell carcinoma
- In situ= atypical cells which doesn’t invade basement membrane
- May or may not progress to SCC
presentation of vulval tumours
- Lumps, bumps, ulceration, skin changes (pigmentation, sensation, pain)
- May be delayed presentation (due to it being in older patients and also due to the intimate nature of the cancer)
are VIN and Vulval SCC related to HPV?
30% of cases are/ 70% are not
- usually HPV 16
- mostly in pre-menopasual women
Vin and vulval SCC are usually asscoiated with
longstanding inflammtory conditions
- Lichen sclerosus
- Squamous hyperplasia
what are the layer sof skin from outr to inner
epidermis
dermis
subcutaenous
Squamous cell carcinoma histology
- Loss of architecture
- Cannot distinguish between dermis and epidermis
- Atypical squamous cells
- Keratin formation by squamous cells
How does vulval cancer spread? Locally
-
Direct extension
- Anus
- Vagina
- Bladder
-
Lymph nodes
- Inguinal (predominantly)
- Iliac
- Para-aortic
-
Distant metastases via blood vessels
- Lungs
- Liver
Vulval cancer histology
- Normal tissue laterally and medially
- Cancer in the middle
- Architecture completely loss- no distinction between dermis and epidermis
- Cell look very abnormal
- Formation of keratin (pink)
Vulval intraepithelial neoplasia (VIN) histology
- Cells look abnormal- no maturation
- Pleiomorphic
- Large nuclei (immature)
- irregular nuclear outline
- No breaking though basement membrane (IN SITU)
- May develop into SCC
Vulval cancer treatment
- Definitive surgery would include removing the primary tumour and nodes, with a higher survival rate in smaller lesions.
- Excision affects cure
before the onset of menstruation the cervix is divisible into 2 parts
the ectocervix
endocervix
ectocervix
- communicates with vagina (low pH)
- Stratified squamous
endocervix
- not in contact with vagina
- Simple columnar (doesn’t need protecting from acidic vagina)
At menstruation, oestrogen causes an anatomical change in the cervix-
eversion of the cervix
eversion of the cervix
- Simple columnar epithelium of the endocervix is now exposed to acidic environment of the vagina –> not v appropriate to cope with acidic environment
- Inflammation
overtime (e.g. women in her 30s) what will happen to the columnar cells of the endocervix
) these columnar cells will undergo metaplasia and become squamous cells, which are better adapted to cope with acidic environment – transformation zone
transitional zone of the cervix
risk of dysplasia - cells undergoing metaplasia are at
risk factors for cervical cancer
- Sexual partners with HPV
- Multiple partners
- Early age of first intercourse
- Early first pregnancy
- Multiple births
- Smoking
- Low socio-economic status
- immunosuppression
Human Papilloma Virus
- DNA virus
- Sexually transmitted
- High risk subtypes cause cancer
high risk subtypes of HPV
HPV 16 and 18
HPV and cervical cancer MOA
- In the cervix they infect the transformation zone
- Produces viral proteins (E6 and E7)
- Inactivates tumour suppressor genes (E6- p53 and E7- Rb)
- Uncontrolled cellular proliferation (hallmark of cancer)
percursor condition of cervical cancer
cervical intraepithelial neoplasia (CIN)
cervical intraepithelial neoplasia (CIN)
- Dysplasia
- Confined to cervical epithelium (in situ- doesn’t breach basement membrane )
- Caused by HPV infection (95%)
CIN can be divided into
CIN 1/2/3 –> SCC
- Defined by the thickness of the cervical epithelium
- If CIN breaches basement membrane – invasive squamous cell carcinoma
CIN histology
- Abnormal cells
- Loss of maturation
- Pleomorphic
- Irregular nuclear membrane
- Clumps of chromatin within nucleus
- Abnormal mitosis
- Full thickness abnormality – CIN3 (hasn’t broken. Through basement membrane
Treatment of CIN
-
CIN1
- Often regresses spontaneously
- Follow up cervical smear in 1 year
-
CIN 2 and
- Needs treatment
- Colposcopy
- Large loop excision of transformation zone (LLETZ)
- Needs treatment
prevention of cervical cancer
- screening
- vaccination
Cervical cancer screening programme
- aged 25-49= eveyr 3 years
- age 50-64= every 5 years
- over 65 only if recent abnormality
brush used to scrape cells from transformation zone- tested for HPV
if positive= cells looked at under microscope
what is the HPV vaccine called and which subtypes does it cover
Gardasil
- Recombinant vaccination
- HPV subtypes 6/11/16/18
who receives the HPV vaccine
girls ages 12-13
- now being given to boys (oral and anul cancer)
- homosexual sex
- protect girls
gardasil protects from
- from cervical, vulval, oral and anal cancers
- lasts 10 years
Invasive cervical cancer
- Squamous cell carcinoma
- Adenocarcinoma
- Less common/ arises from endocervical glandular cells
presentation of cervical cancer
Presentation
- Bleeding
- Post coital
- Inter menstrual
- Post menopausal
- Mass
- Screening
Cytology: squamous cell carcinoma
- Large nuclei
- Pleiomorphism
- Irregular nuclear outlines
Less commonly endocarcinomas
spread pf cervical carcinoma
stage 0 cervical cancer
carcinoma in situ
100% survival
stage 1 cervical cancer
confided to cervix
85% 5 year survival
(most people at this stage at presentation 47%)
stage 2 cervical cancer
disease beyond cervix but not pelvic wall or lower 1/3 of vagina
65% survival
stage 3 cervical cancer
disease to pelvic wall or lower1/3 of vagina
36% 5 year survival
stage 4 cervical cancer
invades bladder, rectum or metastasis
7% survival
Treatment of invasive cervical cancer
- If advanced:
- Hysterectomy
- Lymph node dissection
- Chemoradiotherapy +-